ProQR Therapeutics announces a Phase 1 trial of AX-0810 to evaluate safety and target engagement in cholestatic liver disease. The initiation of the Phase 1 clinical trial for AX-0810 is contingent ...
Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...
Emerging technologies, such as functional near-infrared spectroscopy, offer in-office real-time monitoring for potential ...
Immunologist Shimon Sakaguchi, a co-winner of this year’s Nobel Prize in Physiology or Medicine, said he hopes research in ...
Immuron (IMRN) announced that it has submitted an Investigational New Drug, or IND, application to the FDA for clinical development of IMM-529.
How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer Over the next few years, the analysis of circulating tumor DNA (ctDNA) through liquid biopsy is expected to enter clinical ...
The Coalition for Epidemic Preparedness Innovations (CEPI) partners with AdVAncIng Clinical TRials Excellence in Africa ...
The transformative impact of artificial intelligence (AI) on clinical research, diagnosis, treatment, and our overall understanding of medicine continues to expand. This collection of in-depth ...
Wolters Kluwer Health has introduced the next generation of Lippincott DocuCare, an academic electronic health record (EHR) ...
The Baylor College of Medicine Board of Trustees, Academic Council and Faculty Senate have approved a new Clinical Psychology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback